chr8-56069824-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001146227.3(RPS20):āc.343T>Cā(p.Ser115Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00578 in 1,495,880 control chromosomes in the GnomAD database, including 178 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001146227.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS20 | NM_001146227.3 | c.343T>C | p.Ser115Pro | missense_variant | 5/6 | NP_001139699.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS20 | ENST00000519807.5 | c.343T>C | p.Ser115Pro | missense_variant | 5/6 | 2 | ENSP00000429374 | |||
RPS20 | ENST00000618656.2 | c.325T>C | p.Ser109Pro | missense_variant | 4/5 | 3 | ENSP00000478703 | |||
RPS20 | ENST00000676461.1 | c.*2547+719T>C | intron_variant, NMD_transcript_variant | ENSP00000504670 |
Frequencies
GnomAD3 genomes AF: 0.0194 AC: 2955AN: 152118Hom.: 77 Cov.: 32
GnomAD3 exomes AF: 0.00785 AC: 1209AN: 153948Hom.: 28 AF XY: 0.00747 AC XY: 610AN XY: 81706
GnomAD4 exome AF: 0.00423 AC: 5681AN: 1343644Hom.: 99 Cov.: 22 AF XY: 0.00416 AC XY: 2769AN XY: 665856
GnomAD4 genome AF: 0.0195 AC: 2964AN: 152236Hom.: 79 Cov.: 32 AF XY: 0.0192 AC XY: 1429AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2020 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 15, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at